To view this email as a web page, click here.
 
HHS names FDA acting chief as Gottlieb resignation sparks worry
HHS has named Ned Sharpless, MD, as the acting FDA Commissioner after Scott Gottlieb, MD, resigned last week. Gottlieb's resignation sparked worry among pharma makers—especially generic and biosimilar manufacturers.
Read more
 
Breakthrough nasal spray for depression not without risks
While there are potential serious adverse outcomes from use of a new nasal spray to treat depression, it is being lauded as a breakthrough treatment.
Read more
 
Creative ways biologic innovators are protecting their turf
From our sister brand, Managed Healthcare Executive: As more biosimilar agents are approved by FDA, biologic manufacturers are looking for unique ways to hold on to market share.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.